Comera SPAC Presentation Deck
CLS-003
(to be
announced late
Q1 2022)
CLS-003 and Other Emerging Pipeline Programs
We intend to announce CLS-003 in late Q1 2022 after finalization of our internal assessment;
other pipeline assets in earlier stages of diligence and will be named by the end of 2022
+
Other
Emerging
Pipeline
Programs
Candidate 1
Candidate 2
Candidate 3
Candidate 4
Candidate 5
Candidate 6
Therapeutic Area
Oncology
Oncology
Inflammation
Oncology
Oncology
Oncology,
Inflammation
Source: L.E.K. market research and analysis; ; Peak sales potential reflects maximum estimated sales in a 12-month period following approval.
Peak Market Size
~$15B
-$10B
-$1B
-$3B
-$2B
)<
-$4B
Comera
Peak Asset Sales
Potential
LIFE SCIENCES
$500M - $1B
-
$350M $850M
-
$300M $650M
$350M $600M
$350M $650M
$200M $500M
25View entire presentation